Abstract Pediatric uveitis accounts for 5–10% of all uveitis. Uveitis in children differs from
adult uveitis in that it is commonly asymptomatic and can become chronic and cause …

Systemic juvenile idiopathic arthritis (sJIA) is a very distinctive subtype of juvenile idiopathic
arthritis (JIA) with unique clinical manifestations, associated complications, and therapeutic …

Objective To provide updated guidelines for pharmacologic management of juvenile
idiopathic arthritis (JIA), focusing on treatment of oligoarthritis, temporomandibular joint …

Objectives To describe disease activity 30 years after disease onset in a previously studied
cohort of patients with juvenile idiopathic arthritis (JIA) and reveal predictors of long-term …

A generation ago, children with arthritis faced a lifetime of pain and disability. Today, there
are a multitude of treatment options, including a variety of biologics targeting key cytokines …

Objective To evaluate the safety and efficacy of up to 8 years of etanercept treatment in
patients with polyarticular‐course juvenile rheumatoid arthritis (JRA). Methods Patients with …

ContextThe treatment of juvenile idiopathic arthritis (JIA) has changed markedly in the last
15 years. Many children with JIA are not treated by pediatric rheumatologists. ObjectiveTo …

Juvenile idiopathic arthritis (JIA), a term referring to a group of disorders characterized by
chronic arthritis, is the most common chronic rheumatic illness in children and is a significant …

Chronic pain in adulthood is one of the most costly conditions in modern western society.
However, very little is known about the costs of chronic pain in adolescence. This …

Objective To describe the experiences and perspectives of children and adolescents living
with juvenile idiopathic arthritis (JIA). Methods We conducted a systematic review of …